Timing of influenza antiviral therapy and risk of death in adults hospitalized with influenza-associated pneumonia, FluSurv-NET, 2012-2019.
Mark W TenfordeKameela P NoahAlissa C O'HalloranPam Daily KirleyCora HooverNisha B AldenIsaac ArmisteadJames MeekKimberly Yousey-HindesKyle P OpenoLucy S WittMaya L MonroePatricia A RyanAnna FalkowskiLibby ReegRuth LynfieldMelissa McMahonEmily B HancockMarisa R HoffmanSuzanne McGuireNancy L SpinaChristina B FelsenMaria A GaitanKrista LungEli ShiltzAnn ThomasWilliam SchaffnerH Keipp TalbotMelanie T CrosslandAndrea PriceSvetlana MasalovichKatherine AdamsRachel HolsteinDevi SundaresanTimothy M UyekiCarrie ReedCatherine H BozioShikha GargPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Delayed initiation of antiviral treatment in patients hospitalized with influenza-associated pneumonia was associated with higher risk of death, highlighting the importance of timely initiation of antiviral treatment at admission.